Company press releases

Displaying 101 - 114 of 114 results
Released Company Title Industry Topic
21 Jan 2022
18:00 CET 		ADVICENNE Advicenne Ordinary Shareholders’ Meeting Approved the Project to Transfer Advicenne’s Shares Listing to the Euronext Growth Paris Market and Delisting From the Regulated Market of Euronext Brussels 20103010 Biotechnology Share history
18 Jan 2022
07:00 CET 		ADVICENNE Advicenne annonce un chiffre d’affaires 2021 de 3,3 millions d’euros en hausse de 20% 20103010 Biotechnology Sales
18 Jan 2022
07:00 CET 		ADVICENNE Advicenne Reports 2021 Sales up 20% to €3.3 Million 20103010 Biotechnology Sales
04 Jan 2022
07:00 CET 		ADVICENNE Advicenne Announces Commercialization Agreement with FrostPharma AB for Sibnayal™in the Nordic Region 20103010 Biotechnology News contracts
04 Jan 2022
07:00 CET 		ADVICENNE Advicenne annonce la signature d’un partenariat avec FrostPharma AB pour la commercialisation de Sibnayal™dans les pays nordiques 20103010 Biotechnology News contracts
27 Dec 2021
14:41 CET 		ADVICENNE Advicenne Announces Its Financial Calendar for 2022 20103010 Biotechnology Other financial transaction
27 Dec 2021
14:41 CET 		ADVICENNE Advicenne annonce son calendrier financier 2022 20103010 Biotechnology Other financial transaction
20 Dec 2021
07:00 CET 		ADVICENNE Advicenne Announces Positive Opinion From the French Transparency Commission (HAS) for its Drug Sibnayal™ in dRTA 20103010 Biotechnology New
20 Dec 2021
07:00 CET 		ADVICENNE Advicenne annonce l’avis définitif de la Commission de la Transparence de la HAS pour son médicament Sibnayal™ dans l’ATRd 20103010 Biotechnology New
07 Dec 2021
07:00 CET 		ADVICENNE Advicenne Announces Significant Progress in Marketing Its Lead Product Sibnayal™in Europe 20103010 Biotechnology News contracts
07 Dec 2021
07:00 CET 		ADVICENNE Advicenne annonce des avancées significatives dans la commercialisation de son produit phare Sibnayal™ en Europe 20103010 Biotechnology News contracts
06 Dec 2021
18:00 CET 		ADVICENNE Advicenne annonce la mise à disposition de son document d’enregistrement universel 20103010 Biotechnology Legal
03 Dec 2021
18:00 CET 		ADVICENNE Proposed Transfer of the Listing of Advicenne’s Shares to the Euronext Growth Paris Market and Delisting From the Regulated Market of Euronext Brussels 20103010 Biotechnology New
03 Dec 2021
18:00 CET 		ADVICENNE Projet de transfert de la cotation des titres Advicenne sur le marché Euronext Growth Paris et de la radiation de leur cotation sur le marché réglementé d’Euronext Bruxelles 20103010 Biotechnology New